Beam Therapeutics (BEAM) Other Operating Expenses (2019 - 2025)
Beam Therapeutics (BEAM) reported Other Operating Expenses of -$382.5 million for Q4 2025, down 212.99% year-over-year from $338.5 million in Q4 2024, and down 185.84% quarter-over-quarter from -$133.8 million in Q2 2025.
Beam Therapeutics (BEAM) Other Operating Expenses (2019 - 2025) Analysis & Trends
Beam Therapeutics (BEAM) has 5 years of Other Operating Expenses data on file, last reported at -$382.5 million in Q4 2025.
- Other Operating Expenses for Q4 2025 came in at -$382.5 million, down 212.99% year-over-year; the trailing twelve-month figure through Mar 2026 was -$516.3 million (down 2292.56% YoY), and the FY2025 annual result was -$767.1 million, changed N/A from the prior year.
- Other Operating Expenses eased to -$382.5 million in Q4 2025 per BEAM's latest filing, from -$133.8 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $338.5 million in Q4 2024 and troughed at -$382.5 million in Q4 2025.
- A 3-year average of -$77.0 million and a median of -$118.9 million in 2024 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2021 and 2025: Other Operating Expenses jumped 43.56% in 2021, then plunged 212.99% in 2025.
- A 3-year view of Other Operating Expenses shows it stood at -$1.2 million in 2021, then surged by 28621.23% to $338.5 million in 2024, then sank by 212.99% to -$382.5 million in 2025.
- Business Quant data shows BEAM's Other Operating Expenses at -$382.5 million in Q4 2025, -$133.8 million in Q2 2025, and -$127.2 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Beam Therapeutics | 3.53 Bn | 3.53 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -382.52 Mn |
| Jun 30, 2025 | -133.82 Mn |
| Mar 31, 2025 | -127.16 Mn |
| Dec 31, 2024 | 338.55 Mn |
| Sep 30, 2024 | -118.89 Mn |
| Jun 30, 2024 | -114.08 Mn |
| Mar 31, 2021 | -1.19 Mn |
| Dec 31, 2020 | -54.67 Mn |
| Sep 30, 2020 | 2.87 Mn |
| Jun 30, 2020 | -7.93 Mn |
| Mar 31, 2020 | -2.10 Mn |
| Dec 31, 2019 | -1.48 Mn |
| Sep 30, 2019 | -981,000.00 |
| Jun 30, 2019 | -210,000.00 |
| Mar 31, 2019 | -502,000.00 |